GET A VALUABLE CERTIFICATE FOR JOB MARKET


ACADEMIC RECOGNITION OF 3 OR 6 CREDITS


DESIGNED FOR EXPERTS BY EXPERTS


INFORMATION AND COMMUNICATION ABOUT BENEFIT-RISK OF MEDICINES. BASIC PRINCIPLES.


OBJECTIVES



This module will address medicines risks communication and its place within the frame of communication on medicines.

Objectives:

To identify the key roles, routes and tools of communication on medicines and their risks

To know the evolution of medicines risk communication and overview of the regulatory responsibilities and requirement

To be aware of environmental drug impact communication

Stakeholders, actors and routes in risk communication on medicines

 

MODULE PARTS



  1. Principal actors in communication on medicines risk, of traditional and new forms of communication, of routes of communication and their evolution through time
  2. Basis of risk communication process
  3. Regulatory Responsibilities and Requirements Concerning Medicines Risk Communication
  4. Communication of actual and alleged risks associated to medicines: three different scenarios

 

TRAINER TEAM



Coordinator: Prof Annalisa Capuano (from Università degli Studi della Campania Luigi Vanvitelli)

Expert(s): Dr Paul Benkimoun (from Le Monde), Dr Marie-Pierre Barrouillet (from Université de Bordeaux), Bruce Hugman (Independent), Dr Cristina Scavone (from Università degli Studi della Campania Luigi Vanvitelli).

Introductory level
75 h workload over 3 months (3 ECTS credits)
Key dates
Course calendar
Certificate award
or included in Master Year 2 programme
English language
Online based learning
Student: 1,500 €
Professional: 3,000 €
  Savings could be offered under eligibility conditions.

APPLY NOW

Applications open until September 08th, 2017

Or include this module in your training curriculum choices...

Master Year 2 PhD



Confused? Read the FAQs...

NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners